JP2023509973A5 - - Google Patents
Info
- Publication number
- JP2023509973A5 JP2023509973A5 JP2022542247A JP2022542247A JP2023509973A5 JP 2023509973 A5 JP2023509973 A5 JP 2023509973A5 JP 2022542247 A JP2022542247 A JP 2022542247A JP 2022542247 A JP2022542247 A JP 2022542247A JP 2023509973 A5 JP2023509973 A5 JP 2023509973A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- antibody
- cancer
- antigen
- sequence shown
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026006029A JP2026086455A (ja) | 2020-01-10 | 2026-01-16 | 上皮カドヘリン特異性抗体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20151325 | 2020-01-10 | ||
| EP20151325.6 | 2020-01-10 | ||
| PCT/NL2021/050009 WO2021141492A1 (en) | 2020-01-10 | 2021-01-08 | Epithelial cadherin-specific antibodies |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026006029A Division JP2026086455A (ja) | 2020-01-10 | 2026-01-16 | 上皮カドヘリン特異性抗体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023509973A JP2023509973A (ja) | 2023-03-10 |
| JP2023509973A5 true JP2023509973A5 (cg-RX-API-DMAC7.html) | 2024-01-17 |
Family
ID=69159601
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022542247A Pending JP2023509973A (ja) | 2020-01-10 | 2021-01-08 | 上皮カドヘリン特異性抗体 |
| JP2026006029A Pending JP2026086455A (ja) | 2020-01-10 | 2026-01-16 | 上皮カドヘリン特異性抗体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026006029A Pending JP2026086455A (ja) | 2020-01-10 | 2026-01-16 | 上皮カドヘリン特異性抗体 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240317880A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4087872A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2023509973A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220131527A (cg-RX-API-DMAC7.html) |
| CN (2) | CN115066439A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021206586A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022013601A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3163286A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL294342A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022008391A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021141492A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4681581A (en) | 1983-12-05 | 1987-07-21 | Coates Fredrica V | Adjustable size diaper and folding method therefor |
| US4735210A (en) | 1985-07-05 | 1988-04-05 | Immunomedics, Inc. | Lymphographic and organ imaging method and kit |
| US5101827A (en) | 1985-07-05 | 1992-04-07 | Immunomedics, Inc. | Lymphographic and organ imaging method and kit |
| US5776093A (en) | 1985-07-05 | 1998-07-07 | Immunomedics, Inc. | Method for imaging and treating organs and tissues |
| US5648471A (en) | 1987-12-03 | 1997-07-15 | Centocor, Inc. | One vial method for labeling antibodies with Technetium-99m |
| CA2065299C (en) | 1989-08-09 | 2001-07-24 | Buck A. Rhodes | Direct radiolabeling of antibodies and other proteins with technetium or rhenium |
| US8940501B2 (en) | 2009-01-30 | 2015-01-27 | Whitehead Institute For Biomedical Research | Methods for ligation and uses thereof |
| WO2012058418A2 (en) * | 2010-10-27 | 2012-05-03 | The Research Foundation Of State University Of New York | Compositions targeting the soluble extracellular domain of e-cadherin and related methods for cancer therapy |
| SI2634194T1 (sl) * | 2010-10-29 | 2018-11-30 | Perseus Proteomics Inc. | Anti-cdh3 protitelo, ki ima visoko kapaciteto internalizacije |
| CN107287660A (zh) * | 2011-09-30 | 2017-10-24 | 中外制药株式会社 | 离子浓度依赖性结合分子文库 |
| WO2013081463A2 (en) | 2011-12-02 | 2013-06-06 | Aimm Therapeutics B.V. | Influenza a virus specific antibodies |
| US9534058B2 (en) * | 2012-02-08 | 2017-01-03 | Abbvie Stemcentrx Llc | Anti-CD324 monoclonal antibodies and uses thereof |
| JP2016531915A (ja) * | 2013-08-28 | 2016-10-13 | ステムセントリックス, インコーポレイテッド | 部位特異的抗体コンジュゲーション方法および組成物 |
| EP3572425A1 (en) | 2013-12-17 | 2019-11-27 | AIMM Therapeutics B.V. | Means and methods for counteracting myeloproliferative or lymphoproliferative disorders |
| MX2018006072A (es) * | 2015-11-19 | 2018-08-01 | Squibb Bristol Myers Co | Anticuerpos contra receptor de factor de necrosis de tumor inducido por glucocorticoides (gitr) y usos de los mismos. |
-
2021
- 2021-01-08 KR KR1020227027102A patent/KR20220131527A/ko not_active Ceased
- 2021-01-08 CN CN202180013805.8A patent/CN115066439A/zh active Pending
- 2021-01-08 CA CA3163286A patent/CA3163286A1/en active Pending
- 2021-01-08 JP JP2022542247A patent/JP2023509973A/ja active Pending
- 2021-01-08 EP EP21700098.3A patent/EP4087872A1/en active Pending
- 2021-01-08 AU AU2021206586A patent/AU2021206586A1/en active Pending
- 2021-01-08 IL IL294342A patent/IL294342A/en unknown
- 2021-01-08 MX MX2022008391A patent/MX2022008391A/es unknown
- 2021-01-08 US US17/789,940 patent/US20240317880A1/en active Pending
- 2021-01-08 CN CN202211674336.7A patent/CN116003604A/zh active Pending
- 2021-01-08 BR BR112022013601A patent/BR112022013601A2/pt unknown
- 2021-01-08 WO PCT/NL2021/050009 patent/WO2021141492A1/en not_active Ceased
-
2026
- 2026-01-16 JP JP2026006029A patent/JP2026086455A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7583707B2 (ja) | 抗cd47抗体及びその応用 | |
| JP7461950B2 (ja) | Cd3抗体およびその医薬用途 | |
| CN112969476B (zh) | 多特异性蛋白分子 | |
| CN112574307A (zh) | 抗人Claudin18.2抗体及其应用 | |
| JP2021514664A5 (cg-RX-API-DMAC7.html) | ||
| CA3118775A1 (en) | Anti-cd73 antibody, antigen-binding fragment thereof and application thereof | |
| CN115052896A (zh) | 抗ror1抗体和组合物 | |
| JP2021528047A5 (cg-RX-API-DMAC7.html) | ||
| CN114181310A (zh) | 抗tigit抗体、其药物组合物及用途 | |
| EP4393950A1 (en) | Fap/cd40 binding molecule and medicinal use thereof | |
| TWI797609B (zh) | 抗pd-1和pd-l1的四價雙特異性抗體 | |
| JP2024001073A5 (cg-RX-API-DMAC7.html) | ||
| CN113683697B (zh) | 抗b7-h3抗体、其制备方法及用途 | |
| CN113563473A (zh) | 四价双特异性抗体、其制备方法和用途 | |
| WO2024114676A1 (zh) | Cldn18.2/4-1bb结合蛋白及其医药用途 | |
| WO2023104080A1 (zh) | 抗trop-2抗体或其抗原结合片段 | |
| JP2023525991A5 (cg-RX-API-DMAC7.html) | ||
| CN112805297B (zh) | 抗人类pd-l1抗体及其用途 | |
| JP2025517737A5 (cg-RX-API-DMAC7.html) | ||
| US10781265B2 (en) | Humanized antibodies against Globo H and uses thereof in cancer treatments | |
| WO2025016459A1 (zh) | 一种抗fgfr2/pd-1双特异性抗体 | |
| CN116813786B (zh) | 抗cd73抗体及其应用 | |
| CN113754774A (zh) | 一种抗pd-l1和egfr的四价双特异性抗体 | |
| WO2024131846A1 (en) | Antibody, antigen-binding fragment thereof, and pharmaceutical use thereof | |
| CN115073596B (zh) | 一种人源化Claudin18.2抗体及其应用 |